Michael J Griffith

Title: Michael J Griffith: Innovator in Recombinant Protein Production

Introduction

Michael J Griffith is an accomplished inventor based in San Juan Capistrano, California. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins. His innovative work has the potential to impact treatments for various medical conditions, including Hemophilia.

Latest Patents

Griffith holds a patent for a "Method of producing recombinant vitamin K dependent proteins." This patent describes methods for producing cell lines that exhibit high levels of biologically active recombinant vitamin K dependent proteins. The transfected cell lines do not include heterologous genes for processing enzymes and are not subject to selection pressure, such as methotrexate resistance. Notably, the cell lines he developed can produce Factor VII/VIIa and Factor IX, which are crucial for the treatment of Hemophilia.

Career Highlights

Throughout his career, Griffith has worked with notable organizations, including Aptevo Biotherapeutics LLC and the University of North Carolina at Chapel Hill. His experience in these institutions has allowed him to refine his expertise in biotechnology and contribute to advancements in the field.

Collaborations

Griffith has collaborated with various professionals, including his coworker Samia Mankarious. Their joint efforts have furthered research and development in recombinant protein production.

Conclusion

Michael J Griffith's innovative work in the field of recombinant proteins showcases his dedication to advancing medical treatments. His contributions have the potential to significantly improve the lives of individuals affected by Hemophilia and other related conditions.